Publications of U. Reichl

Sidorenko, Y. & Reichl, U. (2004)A Model for the Influenza Virus Live-Cycle in a Single CellIn: ICSB: 5th International Congress on Systems Biology: Book of abstracts, 382.

Möhler, L., Flockerzi, D., & Reichl, U. (2002)Mathematical Model of Virus Replication in Animal CellsIn: Chemie Ingenieur Technik, 661–662doi: 10.1002/1522-2640(200205)74:5<661::AID-CITE1111661>3.0.CO;2-W.

Trotha, R., Reichl, U., Koenig, W., & Koenig, B. (2002)Validation of a T-RFLP Technique for the Precise Qualitative and Quantitative Characterization of Microbioal Communities by Using an Automated High Throughput Multi-Capillary Electrophoresis DeviceIn: Abstracts of the General Meeting of the American Society for Microbiology, 323.

Pelz, L., Dogra, T., Piasecka, J., Rüdiger, D., Bälkner, M., Boehme, J. D., Kershaw, O., Volckmar, J., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo EfficacyPresented at: 34^th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: 6^th MECP (Multistep Enzyme Catalyzed Processes) CongressVienna (Austria), April 14, 2024.

Genzel, Y., Göbel, S., & Reichl, U.Shaking to very high cell densities - perfusion for virus productionPresented at: Kuhner Large Scale MeetingGirona (Spain), May 29, 2024.

Genzel, Y., Zinnecker, T. M., Göbel, S., & Reichl, U.Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yieldPresented at: 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI)Rio de Janeiro (Brazil), May 7, 2024.

Pelz, L., Rüdiger, D., Hein, M., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Engineered defective interfering particles of influenza A virus for antiviral treatmentPresented at: 33^rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.

Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systemsPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissuesPresented at: KSMB-SMB 2024Seoul (South Korea), June 29, 2024.

Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Zuniga-Banuelos, F. J., Lemke, G., Hoffmann, M., Reichl, U., & Rapp, E.Discovering Rare Sialylated N glycans Holding O Acetylation or Sulfation within the Site-Specific N glycosylation of Human Serum IgAPresented at: SialoGlyco 2024 (International Conference in SialoGlycobiology 2024)Lille (France), June 4, 2024.

Zuniga-Banuelos, F. J., Lemke, G., Hoffmann, M., Reichl, U., & Rapp, E.Including N glycopeptides Bearing Glucuronidated, O Acetylated or Sulfated N glycans in the Analysis of Human Serum Proteins such as Immunoglobulin APresented at: 33rd Joint Glycobiology Meeting (JGM) Hannover (Germany), September 29, 2024.

Zuniga-Banuelos, F. J., Lemke, G., Hoffmann, M., Reichl, U., & Rapp, E.Expanding Glycoproteomics: Including N‑glycopeptides Bearing Glucuronidated, O‑Acetylated or Sulfated N‑glycans in the Analysis of Human Serum Proteins such as Immunoglobulin APresented at: EGC 2024 webinar (European Glycoscience Community Webinar Series)online, September 26, 2024.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: GlycoBioTec 2023Berlin, Germany, January 16, 2023.

Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: 3^rd Japan-Switzerland-Germany Workshop on Biocatalysis and Bioprocess Development Aichi (Japan), September 10, 2023.

Dogra, T., Pelz, L., Boehme, J. D., Baelkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A. D., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 17^th Vaccine CongressGlasgow (Scotland), September 24, 2023.

Dogra, T., Pelz, L., Rüdiger, D., Kupke, S. Y., & Reichl, U.Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: Vir-AI-DIP Workshop Hamburg (Germany), July 18, 2023.